[Safety and tolerability of gabapentin]

Area of Science:

• Neurology
• Pharmacology
• Clinical Medicine

Background:

• Epilepsy is a chronic neurological disorder characterized by recurrent seizures.
• Gabapentin (GBP) is an anticonvulsant medication used in epilepsy management.
• Assessing the safety and tolerability of antiepileptic drugs is crucial for patient care.

Purpose of the Study:

• To comprehensively review the available literature on the safety and tolerability of gabapentin (GBP).
• To evaluate GBP's efficacy in treating epilepsy across various patient demographics.
• To identify common adverse effects associated with GBP therapy.

Main Methods:

• Systematic review of published literature.
• Inclusion of studies involving GBP monotherapy and combination therapy.
• Analysis of safety, adverse effects, and tolerance data in all age groups.

Main Results:

• Gabapentin (GBP) demonstrates excellent tolerability in both monotherapy and combination treatment for epilepsy.
• Commonly reported adverse effects include somnolence, fainting, ataxia, nystagmus, tremor, and headache.
• The incidence and intensity of these side effects were generally low and mild, with dose-related effects noted primarily for fainting and somnolence.

Conclusions:

• Gabapentin (GBP) exhibits a favorable safety and tolerability profile for epilepsy treatment.
• It is effective for managing simple and complex partial seizures, with or without generalization, in patients of all ages.
• GBP is considered a safe option with minimal unwanted side effects in the context of epilepsy management.